Brawn Biotech Limited (BOM:530207)
India
· Delayed Price · Currency is INR 20.27
-0.97 (-4.57%)
At close: Mar 6, 2026
Brawn Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 1.99 | 3.97 | 4.39 | 2.25 | 3.96 | Upgrade
|
| Cash & Short-Term Investments | 1.89 | 1.99 | 3.97 | 4.39 | 2.25 | 3.96 | Upgrade
|
| Cash Growth | -21.41% | -49.80% | -9.46% | 95.36% | -43.31% | -0.90% | Upgrade
|
| Accounts Receivable | - | 34.13 | 38.83 | 53.15 | 28.1 | 92.78 | Upgrade
|
| Other Receivables | - | 0.14 | 0.92 | 0.9 | 9.27 | 10.81 | Upgrade
|
| Receivables | - | 34.47 | 39.96 | 54.21 | 37.49 | 103.74 | Upgrade
|
| Inventory | - | 104.67 | 60.17 | 47.91 | 47.24 | 2.57 | Upgrade
|
| Prepaid Expenses | - | 1.84 | 2.25 | 2.57 | 3.25 | 0.01 | Upgrade
|
| Other Current Assets | - | 32.03 | 25.05 | 24.92 | 31.64 | 16.97 | Upgrade
|
| Total Current Assets | - | 175 | 131.4 | 133.99 | 121.87 | 127.25 | Upgrade
|
| Property, Plant & Equipment | - | 4.6 | 3.33 | 3.72 | 3.86 | 1.42 | Upgrade
|
| Long-Term Accounts Receivable | - | 20.14 | 6.59 | 5.99 | 5.88 | 8.55 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 5.15 | 4.57 | 1.59 | 6.24 | 1.51 | Upgrade
|
| Other Long-Term Assets | - | - | 0 | - | - | -0 | Upgrade
|
| Total Assets | - | 204.89 | 145.89 | 145.3 | 137.85 | 138.74 | Upgrade
|
| Accounts Payable | - | 82.38 | 56.75 | 64.69 | 40.52 | 26.59 | Upgrade
|
| Accrued Expenses | - | 2.8 | 3.5 | 4.69 | 4.93 | 6.2 | Upgrade
|
| Current Income Taxes Payable | - | 0.26 | 0.25 | 1.51 | 7.22 | 7.06 | Upgrade
|
| Other Current Liabilities | - | 7.83 | 4.58 | 9.58 | 10.55 | 9.18 | Upgrade
|
| Total Current Liabilities | - | 93.27 | 65.08 | 80.47 | 63.21 | 49.03 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 0.8 | 1.03 | 0.83 | 0.64 | 1.18 | Upgrade
|
| Other Long-Term Liabilities | - | 77.2 | 29.13 | 0.91 | 1.79 | 0.58 | Upgrade
|
| Total Liabilities | - | 171.27 | 95.24 | 82.21 | 65.64 | 50.79 | Upgrade
|
| Common Stock | - | 30 | 30 | 30 | 30 | 30 | Upgrade
|
| Additional Paid-In Capital | - | 15.2 | 15.2 | 15.2 | 15.2 | 15.2 | Upgrade
|
| Retained Earnings | - | -11.73 | 5.3 | 17.74 | 26.85 | 42.6 | Upgrade
|
| Comprehensive Income & Other | - | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | Upgrade
|
| Shareholders' Equity | 37.05 | 33.62 | 50.65 | 63.09 | 72.2 | 87.95 | Upgrade
|
| Total Liabilities & Equity | - | 204.89 | 145.89 | 145.3 | 137.85 | 138.74 | Upgrade
|
| Net Cash (Debt) | 1.89 | 1.99 | 3.97 | 4.39 | 2.25 | 3.96 | Upgrade
|
| Net Cash Growth | -21.41% | -49.80% | -9.46% | 95.36% | -43.31% | -0.90% | Upgrade
|
| Net Cash Per Share | 0.64 | 0.66 | 1.32 | 1.46 | 0.75 | 1.32 | Upgrade
|
| Filing Date Shares Outstanding | 2.93 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Total Common Shares Outstanding | 2.93 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Working Capital | - | 81.74 | 66.32 | 53.53 | 58.66 | 78.23 | Upgrade
|
| Book Value Per Share | 12.97 | 11.21 | 16.88 | 21.03 | 24.07 | 29.31 | Upgrade
|
| Tangible Book Value | 37.05 | 33.62 | 50.65 | 63.09 | 72.2 | 87.95 | Upgrade
|
| Tangible Book Value Per Share | 12.97 | 11.21 | 16.88 | 21.03 | 24.07 | 29.31 | Upgrade
|
| Machinery | - | 10.24 | 7.83 | 7.71 | 6.75 | 3.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.